Literature DB >> 27434445

Clinical Management of Opioid Use Disorder.

Beth Dunlap1, Adam S Cifu2.   

Abstract

Mesh：

Year:  2016        PMID： 27434445     DOI： 10.1001/jama.2016.9795

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  21 in total

1.  Increasing diversion of methadone in Vancouver, Canada, 2005-2015.

Authors:  Hudson Reddon; Joel Ho; Kora DeBeck; M-J Milloy; Yang Liu; Huiru Dong; Keith Ahamad; Evan Wood; Thomas Kerr; Kanna Hayashi
Journal:  J Subst Abuse Treat       Date:  2017-11-28

2.  Opioid agonist therapy during residential treatment of opioid use disorder: Cohort study on access and outcomes.

Authors:  Sheryl Spithoff; Christopher Meaney; Karen Urbanoski; Katy Harrington; Bill Que; Meldon Kahan; Pamela Leece; Vivian Shehadeh; Frank Sullivan
Journal:  Can Fam Physician       Date:  2019-10       Impact factor: 3.275

3.  A Case of Opioid Overdose and Subsequent Death After Medically Supervised Withdrawal: The Problematic Role of Rapid Tapers for Opioid Use Disorder.

Authors:  Derek C Chang; Jan Klimas; Evan Wood; Nadia Fairbairn
Journal:  J Addict Med       Date:  2018 Jan/Feb       Impact factor: 3.702

4.  Quality of primary care among individuals receiving treatment for opioid use disorder.

Authors:  Sheryl Spithoff; Tara Kiran; Wayne Khuu; Meldon Kahan; Qi Guan; Mina Tadrous; Pamela Leece; Diana Martins; Tara Gomes
Journal:  Can Fam Physician       Date:  2019-05       Impact factor: 3.275

5.  How the paediatric workforce can address the opioid crisis.

Authors:  Scott E Hadland; Evan Wood; Sharon Levy
Journal:  Lancet       Date:  2016-09-24       Impact factor: 79.321

6.  Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year.

Authors:  George Pro; Jeff Utter; Shane Haberstroh; Julie A Baldwin
Journal:  Drug Alcohol Depend       Date:  2020-03-07       Impact factor: 4.492

7.  Leptin status alters buprenorphine-induced antinociception in obese mice with dysfunctional leptin receptors.

Authors:  Zachary Glovak; Sara Mihalko; Helen A Baghdoyan; Ralph Lydic
Journal:  Neurosci Lett       Date:  2017-09-08       Impact factor: 3.046

8.  Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems.

Authors:  Denise M Boudreau; Gwen Lapham; Eric A Johnson; Jennifer F Bobb; Abigail G Matthews; Jennifer McCormack; David Liu; Cynthia I Campbell; Rebecca C Rossom; Ingrid A Binswanger; Bobbi Jo Yarborough; Julia H Arnsten; Chinazo O Cunningham; Joseph E Glass; Mark T Murphy; Mohammad Zare; Rulin C Hechter; Brian Ahmedani; Jordan M Braciszewski; Viviana E Horigian; José Szapocznik; Jeffrey H Samet; Andrew J Saxon; Robert P Schwartz; Katharine A Bradley
Journal:  J Subst Abuse Treat       Date:  2020-03

9.  Routine Assessment of Symptoms of Substance Use Disorders in Primary Care: Prevalence and Severity of Reported Symptoms.

Authors:  Mikko Sayre; Gwen T Lapham; Amy K Lee; Malia Oliver; Jennifer F Bobb; Ryan M Caldeiro; Katharine A Bradley
Journal:  J Gen Intern Med       Date:  2020-01-23       Impact factor: 5.128

10.  Prevalence and treatment of opioid use disorders among primary care patients in six health systems.

Authors:  Gwen Lapham; Denise M Boudreau; Eric A Johnson; Jennifer F Bobb; Abigail G Matthews; Jennifer McCormack; David Liu; Jeffrey H Samet; Andrew J Saxon; Cynthia I Campbell; Joseph E Glass; Rebecca C Rossom; Mark T Murphy; Ingrid A Binswanger; Bobbi Jo H Yarborough; Katharine A Bradley
Journal:  Drug Alcohol Depend       Date:  2019-11-15       Impact factor: 4.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.